financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Elicio Therapeutics Names Preetam Shah CFO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Elicio Therapeutics Names Preetam Shah CFO
Mar 24, 2025 5:11 AM

07:57 AM EDT, 03/24/2025 (MT Newswires) -- Elicio Therapeutics ( ELTX ) said Monday that it has named Preetam Shah as its chief financial officer and chief strategy officer, starting immediately.

Shah previously was CFO and chief business officer of biotech firm Cidara Therapeutics (CDTX).

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sweetgreen Insider Sold Shares Worth $1,178,685, According to a Recent SEC Filing
Sweetgreen Insider Sold Shares Worth $1,178,685, According to a Recent SEC Filing
Nov 29, 2024
03:31 AM EST, 11/29/2024 (MT Newswires) -- Nicolas Jammet, Director, Chief Concept Officer, on November 25, 2024, sold 26,193 shares in Sweetgreen ( SG ) for $1,178,685. Following the Form 4 filing with the SEC, Jammet has control over a total of 1,930,233 shares of the company, with 1,930,233 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1477815/000141588924027889/xslF345X05/form4-11272024_101104.xml ...
 Ani Pharmaceuticals Insider Sold Shares Worth $1,941,442, According to a Recent SEC Filing
Ani Pharmaceuticals Insider Sold Shares Worth $1,941,442, According to a Recent SEC Filing
Nov 29, 2024
03:32 AM EST, 11/29/2024 (MT Newswires) -- Nikhil Lalwani, Director, President & Chief Executive Officer, on November 26, 2024, sold 33,481 shares in Ani Pharmaceuticals ( ANIP ) for $1,941,442. Following the Form 4 filing with the SEC, Lalwani has control over a total of 370,378 shares of the company, with 370,378 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1023024/000182262924000014/xslF345X05/wk-form4_1732747122.xml ...
 Protagonist Therapeutics Insider Sold Shares Worth $4,680,749, According to a Recent SEC Filing
Protagonist Therapeutics Insider Sold Shares Worth $4,680,749, According to a Recent SEC Filing
Nov 29, 2024
03:30 AM EST, 11/29/2024 (MT Newswires) -- Dinesh V Patel, Director, President and Chief Executive Officer, on November 25, 2024, sold 100,000 shares in Protagonist Therapeutics ( PTGX ) for $4,680,749. Following the Form 4 filing with the SEC, Patel has control over a total of 408,455 shares of the company, with 408,455 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1377121/000110465924123806/xslF345X05/tm2429758-1_4seq1.xml ...
 Sweetgreen Insider Sold Shares Worth $1,170,180, According to a Recent SEC Filing
Sweetgreen Insider Sold Shares Worth $1,170,180, According to a Recent SEC Filing
Nov 29, 2024
03:31 AM EST, 11/29/2024 (MT Newswires) -- Nathaniel Ru, Director, Chief Brand Officer, on November 25, 2024, sold 26,004 shares in Sweetgreen ( SG ) for $1,170,180. Following the Form 4 filing with the SEC, Ru has control over a total of 1,952,129 shares of the company, with 1,952,129 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1477815/000141588924027887/xslF345X05/form4-11272024_101130.xml ...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved